ADXN
Price
$8.99
Change
+$0.94 (+11.68%)
Updated
Dec 3 closing price
Capitalization
10.12M
Intraday BUY SELL Signals
XRTX
Price
$0.63
Change
-$0.01 (-1.56%)
Updated
Dec 3 closing price
Capitalization
4.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADXN vs XRTX

Header iconADXN vs XRTX Comparison
Open Charts ADXN vs XRTXBanner chart's image
Addex Therapeutics
Price$8.99
Change+$0.94 (+11.68%)
Volume$11.4K
Capitalization10.12M
XORTX Therapeutics
Price$0.63
Change-$0.01 (-1.56%)
Volume$10.3K
Capitalization4.24M
ADXN vs XRTX Comparison Chart in %
ADXN
Daily Signal:
Gain/Loss:
XRTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADXN vs. XRTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and XRTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ADXN: $8.05 vs. XRTX: $0.63)
Brand notoriety: ADXN and XRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 3% vs. XRTX: 0%
Market capitalization -- ADXN: $10.12M vs. XRTX: $4.24M
ADXN [@Biotechnology] is valued at $10.12M. XRTX’s [@Biotechnology] market capitalization is $4.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whileXRTX’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • XRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than XRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 3 TA indicator(s) are bullish while XRTX’s TA Score has 3 bullish TA indicator(s).

  • ADXN’s TA Score: 3 bullish, 6 bearish.
  • XRTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, XRTX is a better buy in the short-term than ADXN.

Price Growth

ADXN (@Biotechnology) experienced а +10.27% price change this week, while XRTX (@Biotechnology) price change was +3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADXN($10.1M) has a higher market cap than XRTX($4.24M). ADXN YTD gains are higher at: 15.000 vs. XRTX (-44.166). XRTX has higher annual earnings (EBITDA): -3.28M vs. ADXN (-12.19M). ADXN has more cash in the bank: 3.35M vs. XRTX (1.06M). ADXN has less debt than XRTX: ADXN (43.8K) vs XRTX (80.5K). ADXN has higher revenues than XRTX: ADXN (556K) vs XRTX (0).
ADXNXRTXADXN / XRTX
Capitalization10.1M4.24M238%
EBITDA-12.19M-3.28M371%
Gain YTD15.000-44.166-34%
P/E RatioN/A8.00-
Revenue556K0-
Total Cash3.35M1.06M316%
Total Debt43.8K80.5K54%
FUNDAMENTALS RATINGS
ADXN vs XRTX: Fundamental Ratings
ADXN
XRTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1698
PRICE GROWTH RATING
1..100
7882
P/E GROWTH RATING
1..100
10070
SEASONALITY SCORE
1..100
3685

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADXN's Valuation (40) in the null industry is in the same range as XRTX (52). This means that ADXN’s stock grew similarly to XRTX’s over the last 12 months.

ADXN's Profit vs Risk Rating (100) in the null industry is in the same range as XRTX (100). This means that ADXN’s stock grew similarly to XRTX’s over the last 12 months.

ADXN's SMR Rating (16) in the null industry is significantly better than the same rating for XRTX (98). This means that ADXN’s stock grew significantly faster than XRTX’s over the last 12 months.

ADXN's Price Growth Rating (78) in the null industry is in the same range as XRTX (82). This means that ADXN’s stock grew similarly to XRTX’s over the last 12 months.

XRTX's P/E Growth Rating (70) in the null industry is in the same range as ADXN (100). This means that XRTX’s stock grew similarly to ADXN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADXNXRTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
85%
MACD
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signal:
Gain/Loss:
XRTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUS9.850.13
+1.34%
NuSkin Enterprises
ATI98.66-0.48
-0.48%
ATI
RXRX4.33-0.03
-0.69%
Recursion Pharmaceuticals
TSQ4.88-0.11
-2.20%
Townsquare Media
ONCO2.48-0.16
-6.06%
Onconetix Inc

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
-1.83%
ANVS - ADXN
43%
Loosely correlated
-1.80%
CVM - ADXN
39%
Loosely correlated
-0.43%
XRTX - ADXN
27%
Poorly correlated
+2.97%
KZIA - ADXN
25%
Poorly correlated
+12.68%
ARTV - ADXN
24%
Poorly correlated
-3.75%
More

XRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
+2.97%
BCDA - XRTX
43%
Loosely correlated
-0.72%
SPHDF - XRTX
32%
Poorly correlated
N/A
KZR - XRTX
28%
Poorly correlated
-0.48%
ADXN - XRTX
27%
Poorly correlated
-1.83%
BYSI - XRTX
26%
Poorly correlated
-3.98%
More